Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carvana Co (CVNA) vs Nuwellis Inc (NUWE) Price & Performance

Carvana CoTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Carvana Co vs Nuwellis Inc — how do they compare? Carvana Co trades at $71.97 (market cap $79.17B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: Carvana Co is far larger — about 145854.8× Nuwellis Inc's market cap, and Carvana Co is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

CVNANUWE
Market Cap
$79.17B$542.80K
Sector
Consumer CyclicalTechnology
52-Week High
$95.69$220.50
52-Week Low
$56.27$1.42
Enterprise Value
$81.65B-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carvana Co

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

About Carvana Co

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.

Read more on CVNA

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE